Levana.ai

Company Overview

Snapshot

Founded in May 2022 by Ilana Kwartin, Alon Ben-Shoshan, and Roded Konforty, Levana.ai operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-based solution for personalized women's prescriptions.

Business overview

Levana.ai is a Health Tech & Life Sciences company developing an AI-based platform designed to personalize women's prescriptions. The company's core technology provides recommendations to doctors on medication dosage and timing, tailored to individual patient cycles. It serves the digital healthcare market, specifically addressing patient engagement within the FemTech sector, and targets both patients and pharmaceutical companies.

Strategic signal

In June 2023, Levana.ai was highlighted for its innovative AI-based solution, which was inspired by the founder's personal experience in FemTech. This signals a strong, mission-driven approach to addressing a critical unmet need in women's healthcare, positioning the company as a potential disruptor in personalized medicine.

Company Intelligence Q&A

When was Levana.ai founded and by whom?

Levana.ai was founded in May 2022 by Ilana Kwartin, Alon Ben-Shoshan, and Roded Konforty.

What is the primary focus of Levana.ai's technology?

Levana.ai focuses on developing an AI-based platform to personalize women's prescriptions, providing doctors with recommendations on medication dosage and timing based on individual patient cycles.

What market does Levana.ai primarily serve?

Levana.ai primarily serves the digital healthcare market, with a specific focus on patient engagement within the FemTech sector.

What is the current stage of Levana.ai's product development?

Levana.ai's product is currently in the R&D stage, with its AI-based solution for personalized women's prescriptions under active development.

Where are Levana.ai's main operational locations?

Levana.ai has offices in Tel Aviv-Yafo, Israel, and Palo Alto, CA, USA.